Labeling of a Serotoninergic Ligand with 18F : [18F] SetoperoneC. CrouzelJohn Wiley and Sons1988DOI 10.1002/jlcr.2580250407
Effect of Serotonin Antagonism in Schizophrenia: A Pilot Study with SetoperoneDominique L. S. CeulemansSpringer1985DOI 10.1007/bf00428197
Sustained 5HT2A Receptor Occupancy of Ziprasidone Using Pet Ligand 18F Setoperone in Healthy VolunteersA. FischmanElsevier Science1996DOI 10.1016/0924-9338(96)89339-4
Decreased Serotonin 2A Receptor Densities in Neuroleptic-Naive Patients With Schizophrenia: A PET Study Using [18F]SetoperoneNgan, E. T.C.American Psychiatric Publishing Inc2000DOI 10.1176/appi.ajp.157.6.1016
Binding Potential of [18F]Setoperone: Reproducibility of Measures by the Simplified Reference Tissue MethodHoule, S.NeuroImage1998DOI 10.1016/s1053-8119(18)31890-1
Prefrontal Cortex 5-HT2 Receptors in Depression: An [18F]Setoperone PET Imaging StudyMeyer, Jeffrey H.American Psychiatric Association Publishing1999DOI 10.1176/ajp.156.7.1029
161. A Voxel-by-voxel Analysis of [18F] Setoperone PET Serotonin 2A Receptor Data in SchizophreniaN.P.L.G. VerhoeffElsevier Science2000DOI 10.1016/s0006-3223(00)00423-6
P-17-2 - Sustained 5HT2A Receptor Occupancy of Ziprasidone Using Pet Ligand 18F Setoperone in Healthy VolunteersA. FischmanEuropean Neuropsychopharmacology1996DOI 10.1016/0924-977x(96)88128-4
Reliability of a Simple Non-invasive Method for the Evaluation of 5-HT2 Receptors Using [18F]-setoperone PET ImagingKAPUR, SHITIJLippincott Williams and Wilkins1997DOI 10.1097/00006231-199705000-00002
Synthesis, Affinity and Specificity of 18F-setoperone, a Potential Ligand for In-vivo Imaging of Cortical Serotonin ReceptorsMaziere, B.Elsevier Science1988DOI 10.1016/0883-2897(88)90018-9
The Effects of Single Dose Nefazodone and Paroxetine Upon 5-HT2A Binding Potential in Humans Using [18F]-setoperone PETJ. H. MeyerPsychopharmacology1999DOI 10.1007/s002130051004
Electroconvulsive Shock Decreases Binding to 5-HT2 Receptors in Nonhuman Primates: An in Vivo Positron Emission Tomography Study with [18F]setoperoneElissa M. StromeElsevier Science2005DOI 10.1016/j.biopsych.2005.01.025